anti-FAU antibody product blog
Tags: Antibody; Monoclonal Antibody; FAU; anti-FAU antibody;
The FAU n/a (Catalog #MBS6011747) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The FAU (FAU,Ubiquitin-like protein FUBI,) reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s FAU can be used in a range of immunoassay formats including, but not limited to, ELISA (EL/EIA), Western Blot (WB).Suitable for use in Western Blot, ELISA.
Dilution: ELISA: 1:1000
Western Blot: 1:1000~8000. Researchers should empirically determine the suitability of the FAU n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
This gene is the cellular homolog of the fox sequence in the Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV). It encodes a fusion protein consisting of the ubiquitin-like protein fubi at the N terminus and ribosomal protein S30 at the C terminus. It has been proposed that the fusion protein is post-translationally processed to generate free fubi and free ribosomal protein S30. Fubi is a member of the ubiquitin family, and ribosomal protein S30 belongs to the S30E family of ribosomal proteins. Whereas the function of fubi is currently unknown, ribosomal protein S30 is a component of the 40S subunit of the cytoplasmic ribosome. Pseudogenes derived from this gene are present in the genome. Similar to ribosomal protein S30, ribosomal proteins S27a and L40 are synthesized as fusion proteins with ubiquitin.
Immunogen: FAU Mab is generated from mouse immunized with FAU recombinant protein. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing FAU are readily searchable from our website. Different antibodies against the same target such as FAU may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.